Weissman CR

Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.

10 papers · ORCID

ArticleKetamine

Comparing transcranial magnetic stimulation and esketamine treatment response trajectories in resistant depression.

Benster LL, Kohn JN, Wade B +5

Europe PMC2026
ArticlePsychedelics

From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice.

Kim J, Lochhead L, Weissman CR

Europe PMC2026
ArticlePsychedelics

Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use.

Bhatt KV, Friedman J, Benster L +5

Europe PMC2026
ArticleKetamine

The use of repetitive transcranial magnetic stimulation (rTMS), electroconvulsive therapy (ECT), ketamine, and esketamine in reducing suicidality in major depressive disorder: A comprehensive narrative review.

Menon T, Lu A, Arulmozhi A +7

Europe PMC2026
ArticlePsychedelics

A Systematic Review of Study Design and Placebo Controls in Psychedelic Research.

Wen A, Singhal N, Jones BDM +6

Europe PMC2024
ArticlePsilocybin

The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects.

Bhatt KV, Weissman CR

Europe PMC2024
ArticlePsychedelics

Correction to "On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review".

Zeifman RJ, Singhal N, Breslow L +1

Europe PMC2022
ArticlePsilocybin

On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.

Zeifman RJ, Singhal N, Breslow L +1

Europe PMC2021
ArticleAyahuasca

Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial.

Zeifman RJ, Singhal N, Dos Santos RG +4

Europe PMC2021
ArticlePsilocybin

Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.

Anderson T, Petranker R, Rosenbaum D +5

Europe PMC2019